ClinicalTrials.gg
Not yet recruitingNCT06699641Updated Nov 21, 2024

The Kampala Trauma Score in the Outcome of Polytrauma Patients

An observational study in Polytrauma Patients, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-11-21.

Sponsored by Assiut University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
110
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The goal of this observational study is to learn about the predictive value of the Kampala Trauma Score in Egypt.

The main question it aims to answer is:

How does the performance of the Kampala Trauma Score compare to the Estimated Injury Severity Score in predicting outcomes for multi-traumatic patients in Egypt? Participants are adult polytrauma patients admitted to the emergency department during the study period.

Read the detailed description

Two prominent scoring systems used in trauma care are the Kampala Trauma Score (KTS) and the Estimated Injury Severity Score (EISS). The KTS was specifically designed for use in low-resource settings, offering a practical tool for predicting patient outcomes based on readily available clinical data. This score integrates parameters such as age, systolic blood pressure, and Glasgow Coma Scale (GCS) scores, making it suitable for environments where advanced diagnostic tools may be lacking. Previous research has demonstrated the KTS's utility in various resource-limited settings, highlighting its role in effectively stratifying trauma patients and guiding triage decisions.

In contrast, the Estimated Injury Severity Score (EISS) is an adaptation of the Injury Severity Score (ISS), which incorporates both clinical and radiographic data to assess trauma severity comprehensively. The EISS uses an estimated approach to account for the often incomplete or preliminary information available in some clinical settings, aiming to provide a robust prediction of patient outcomes. While it is a more comprehensive tool than the KTS, its reliance on advanced imaging and detailed clinical information may limit its applicability in settings with restricted resources.

This study aims to conduct a cross-sectional comparison of the KTS and EISS to evaluate their relative effectiveness in assessing trauma severity and predicting patient outcomes. The results will provide valuable insights into the optimal use of trauma scoring systems and potentially inform improvements in trauma care practices

02

Conditions studied

  • Polytrauma Patients

Browse trials for

03

In context

Multiple Trauma

139 studies on the registry are indexed under Multiple Trauma; 32 are open to participants now.

This study's planned enrollment of 110 is below the median of 200 across 84 observational studies indexed under Multiple Trauma.

Browse Multiple Trauma studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Polytrauma patients admitted to the emergency departments at Assiut University Hospital located in Assiut/Egypt and Suez Canal University Hospital located in Ismailia/Egypt.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult polytrauma patients
  • Both genders

Exclusion criteria

Exclusion Criteria:

  • Patients with incomplete data or those who decline participation.
  • Patients with multiple comorbidities.
  • Patients managed outside the hospital.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
110 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Outcome of polytrauma patients as assessed by the Kampala Trauma Score

    From 0 to 10 9-10 = mild 7-8 = moderate \<6 = severe

    Time frame: From admission to 24 hours post admission

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06699641
Lead sponsor
Assiut University
Responsible party
Ahmed Abdallah Sayed Sawy (Resident, Assiut University) — Principal investigator
First posted
Nov 21, 2024
Start date
Jan 1, 2025 (estimated)
Primary completion
Jan 1, 2026 (estimated)
Completion
Mar 1, 2026 (estimated)
Last update
Nov 21, 2024

Study contacts

Ahmed A Sawy, MBBCH
Contact
ahmed.16266110@med.aun.edu.eg
+201069369158
Walaa A Siam, MD
Contact
Walaa.adel@med.suez.edu.eg
+201000369868

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion